BACKGROUND: Readmission within 30 days is increasingly evaluated as a measure of quality of care. There are few data on the rates of readmission after subarachnoid hemorrhage (SAH). OBJECTIVE: We sought to determine the predictors of 30-day readmission in patients with SAH. METHODS: We prospectively identified 283 patients with SAH admitted between 2006 and 2012. Readmission was determined by means of an automated query with confirmation in the electronic medical record. RESULTS: Overall, 21 (8 %) patients were readmitted for infection (n = 8), headache (n = 5), hydrocephalus (n = 4), cardiovascular causes (n = 2), medication-related complications (n = 1), and cerebral ischemia (n = 1). Readmission was associated with longer intensive care unit (ICU) length of stay (LOS) (15.4 [13.4-19.3] vs. 12.2 [8.2-18.5] days, P = 0.02), hospital LOS (22.2 [17.4-23.0] vs. 16.8 [12.0-24.1] days, P = 0.01), and placement of an external ventricular drain (EVD, OR 3.9, 95 % CI 1.3-12.0, P = 0.01). Readmission was not associated with admission neurologic grade, NIH Stroke scale at 14 days, modified Rankin scale at 3 months, history of cardiovascular disease, or radiographic cerebral infarction (P > 0.1). CONCLUSIONS: Demographics, severity of neurologic injury, radiographic cerebral infarction, and outcomes were not associated with readmission after SAH. Markers of a more complicated hospital course (ICU and hospital LOS, EVD placement) were associated with 30-day readmission. Most readmissions were for infections acquired after discharge. Readmission within 30 days is difficult to predict, and, since the most common reason was infection acquired after discharge, it may be difficult to prevent without an integrated health system and coordinated care.
BACKGROUND: Readmission within 30 days is increasingly evaluated as a measure of quality of care. There are few data on the rates of readmission after subarachnoid hemorrhage (SAH). OBJECTIVE: We sought to determine the predictors of 30-day readmission in patients with SAH. METHODS: We prospectively identified 283 patients with SAH admitted between 2006 and 2012. Readmission was determined by means of an automated query with confirmation in the electronic medical record. RESULTS: Overall, 21 (8 %) patients were readmitted for infection (n = 8), headache (n = 5), hydrocephalus (n = 4), cardiovascular causes (n = 2), medication-related complications (n = 1), and cerebral ischemia (n = 1). Readmission was associated with longer intensive care unit (ICU) length of stay (LOS) (15.4 [13.4-19.3] vs. 12.2 [8.2-18.5] days, P = 0.02), hospital LOS (22.2 [17.4-23.0] vs. 16.8 [12.0-24.1] days, P = 0.01), and placement of an external ventricular drain (EVD, OR 3.9, 95 % CI 1.3-12.0, P = 0.01). Readmission was not associated with admission neurologic grade, NIH Stroke scale at 14 days, modified Rankin scale at 3 months, history of cardiovascular disease, or radiographic cerebral infarction (P > 0.1). CONCLUSIONS: Demographics, severity of neurologic injury, radiographic cerebral infarction, and outcomes were not associated with readmission after SAH. Markers of a more complicated hospital course (ICU and hospital LOS, EVD placement) were associated with 30-day readmission. Most readmissions were for infections acquired after discharge. Readmission within 30 days is difficult to predict, and, since the most common reason was infection acquired after discharge, it may be difficult to prevent without an integrated health system and coordinated care.
Authors: Paul Feigenbaum; Estee Neuwirth; Linda Trowbridge; Serge Teplitsky; Carol Ann Barnes; Emily Fireman; Jann Dorman; Jim Bellows Journal: Med Care Date: 2012-07 Impact factor: 2.983
Authors: E Sander Connolly; Alejandro A Rabinstein; J Ricardo Carhuapoma; Colin P Derdeyn; Jacques Dion; Randall T Higashida; Brian L Hoh; Catherine J Kirkness; Andrew M Naidech; Christopher S Ogilvy; Aman B Patel; B Gregory Thompson; Paul Vespa Journal: Stroke Date: 2012-05-03 Impact factor: 7.914
Authors: Michael N Diringer; Thomas P Bleck; J Claude Hemphill; David Menon; Lori Shutter; Paul Vespa; Nicolas Bruder; E Sander Connolly; Giuseppe Citerio; Daryl Gress; Daniel Hänggi; Brian L Hoh; Giuseppe Lanzino; Peter Le Roux; Alejandro Rabinstein; Erich Schmutzhard; Nino Stocchetti; Jose I Suarez; Miriam Treggiari; Ming-Yuan Tseng; Mervyn D I Vergouwen; Stefan Wolf; Gregory Zipfel Journal: Neurocrit Care Date: 2011-09 Impact factor: 3.210
Authors: Shannon M Dunlay; Susan A Weston; Jill M Killian; Malcolm R Bell; Allan S Jaffe; Véronique L Roger Journal: Ann Intern Med Date: 2012-07-03 Impact factor: 25.391
Authors: Jeffrey D Klopfenstein; Louis J Kim; Iman Feiz-Erfan; Jonathan S Hott; Pam Goslar; Joseph M Zabramski; Robert F Spetzler Journal: J Neurosurg Date: 2004-02 Impact factor: 5.115
Authors: Eric B Schneider; Omar Hyder; Christopher L Wolfgang; Kenzo Hirose; Michael A Choti; Martin A Makary; Joseph M Herman; John L Cameron; Timothy M Pawlik Journal: J Am Coll Surg Date: 2012-08-24 Impact factor: 6.113
Authors: Robert B Dorman; Christopher J Miller; Daniel B Leslie; Federico J Serrot; Bridget Slusarek; Henry Buchwald; John E Connett; Sayeed Ikramuddin Journal: PLoS One Date: 2012-03-07 Impact factor: 3.240
Authors: John W Liang; Laura Cifrese; Lili Velickovic Ostojic; Syed O Shah; Mandip S Dhamoon Journal: Neurocrit Care Date: 2018-12 Impact factor: 3.210
Authors: Adam Kardon; Robert S Murray; Mazhar Khalid; Luana Colloca; J Marc Simard; Neeraj Badjatia; Sarah B Murthi; Nicholas A Morris Journal: Neurohospitalist Date: 2022-05-12
Authors: Jacob K Greenberg; Ridhima Guniganti; Eric J Arias; Kshitij Desai; Chad W Washington; Yan Yan; Hua Weng; Chengjie Xiong; Emily Fondahn; DeWitte T Cross; Christopher J Moran; Keith M Rich; Michael R Chicoine; Rajat Dhar; Ralph G Dacey; Colin P Derdeyn; Gregory J Zipfel Journal: J Neurosurg Date: 2016-08-05 Impact factor: 5.115
Authors: Jacob K Greenberg; Chad W Washington; Ridhima Guniganti; Ralph G Dacey; Colin P Derdeyn; Gregory J Zipfel Journal: J Neurosurg Date: 2015-09-11 Impact factor: 5.115
Authors: Kathryn A Morbitzer; J Dedrick Jordan; Kelly A Sullivan; Emily A Durr; Casey M Olm-Shipman; Denise H Rhoney Journal: Neurocrit Care Date: 2016-10 Impact factor: 3.210
Authors: Hao Wang; Carol Johnson; Richard D Robinson; Vicki A Nejtek; Chet D Schrader; JoAnna Leuck; Johnbosco Umejiego; Allison Trop; Kathleen A Delaney; Nestor R Zenarosa Journal: BMC Health Serv Res Date: 2016-10-10 Impact factor: 2.655
Authors: Corey R Fehnel; William B Gormley; Hormuzdiyar Dasenbrock; Yoojin Lee; Faith Robertson; Alexandra G Ellis; Vincent Mor; Susan L Mitchell Journal: J Am Heart Assoc Date: 2017-10-24 Impact factor: 5.501